STOCK COMMENTS / EPS CHANGESAllegiant Travel (ALGT) estimates raised at UBS through 2013, UBS said. Solid guidance for Q3. Buy rating and $75 price target. Cabela's (CAB) estimates, target boosted at Credit Suisse. Shares of CAB now seen reaching $62, according to Credit Suisse. Estimates also upped, given higher expected comp sales. Outperform rating. Community Health Systems (CYH) target raised at Jefferies to $29, Jefferies said. Easy 2H12 comps and discounted valuation could ignite upward momentum. Hold rating. Medtronic (MDT) target raised at Oppenheimer to $48, Oppenheimer said. Recent peer-group multiple expansion. Outperform rating. Northern Trust (NTRS) numbers lowered at Jefferies. Shares of NTRS now seen reaching $48, Jefferies said. Estimates also lowered on efficiency initiatives. Hold rating. Ocwen Financial (OCN) numbers raised at KBW. Shares of OCN now seen reaching $40, according to Keefe, Bruyette & Woods said. Homeward acquisition should add to earnings. Outperform rating. Onyx Pharmaceuticals (ONXX) numbers increased at BofA/Merrill. ONXX estimates were raised through 2013, Bank of America/Merrill Lynch said. Expect higher Kyprolis sales. Buy rating and new $101 price target. Constellation Brands (STZ - Get Report) numbers raised at UBS. Shares of STZ now seen reaching $42. Estimates also increased as strong depletion trends support positive outlook. Buy rating. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.